The right mass does not prove the right peptide

What the measurement shows

A matching intact mass is strong evidence of the right composition: the right number of each element. It cannot tell apart molecules with the same composition arranged differently, and peptides have several of those:

• Leucine and isoleucine are isomers with identical masses, so a sequence with one in place of the other weighs the same.
• Epimers: a residue in the D- instead of the L-form, from racemization during synthesis, has the same mass.
• Isoaspartate: aspartic acid isomerized through a ring intermediate keeps its mass.
• Reordered sequences: the same residues in a different order have the same intact mass.

Why it matters

Same-mass variants can behave differently in an assay while passing a mass check. Diastereomers and isoaspartate forms also tend to elute close to the main peak in HPLC, so they are easy to miss twice.

How to check

• Sequence order is confirmed by tandem mass spectrometry: the fragment ladder reads the residues in order. Each peptide reference entry lists its expected b and y ions.
• Stereochemistry and isoaspartate need chromatography that separates them, or chiral analysis after hydrolysis.
• Check observed values against the sequence with mass match, remembering that a match means consistent, not proven.

Frequently asked questions

Can high-resolution mass spectrometry tell leucine from isoleucine?

Not from the intact mass, which is identical. Specialized fragmentation methods can, but they are not part of routine identity testing.

Is a mass check still worth doing?

Yes. It rules out the wrong composition, deletions, missing modifications and many synthesis errors. It is a necessary check, not a sufficient one.

Sources & Further Reading

1. Biemann K. Contributions of mass spectrometry to peptide and protein structure. Biomedical and Environmental Mass Spectrometry 1988;16(1–12):99–111. doi:10.1002/bms.1200160119
2. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. Journal of Biological Chemistry 1987;262(2):785–794. doi:10.1016/S0021-9258(19)75855-4
3. Palasek SA, Cox ZJ, Collins JM. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis. Journal of Peptide Science 2007;13(3):143–148. doi:10.1002/psc.804
4. D'Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, et al. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis 2014;101:2–30. doi:10.1016/j.jpba.2014.06.012

Cosmic Peptides. (2026, October 25). The right mass does not prove the right peptide. Cosmic Peptides Research Library. Retrieved October 26, 2026, from https://cosmicpeptides.com/research/myths/same-mass-different-peptide

@misc{cosmicpeptides_research_myths_same_mass_different_peptide,
  author       = {{Cosmic Peptides}},
  title        = {The right mass does not prove the right peptide},
  howpublished = {Cosmic Peptides Research Library},
  year         = {2026},
  month        = oct,
  url          = {https://cosmicpeptides.com/research/myths/same-mass-different-peptide},
  urldate      = {2026-10-26},
  note         = {Last reviewed 2026-10-25}
}

TY  - ELEC
AU  - Cosmic Peptides
TI  - The right mass does not prove the right peptide
T2  - Cosmic Peptides Research Library
PB  - Cosmic Peptides
PY  - 2026
DA  - 2026/10/25
UR  - https://cosmicpeptides.com/research/myths/same-mass-different-peptide
Y2  - 2026/10/26
LA  - en
ER  -